NAUT
Income statement / Annual
Last year (2025), Nautilus Biotechnology Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Nautilus Biotechnology Inc's net income was -$59.00 M.
See Nautilus Biotechnology Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$6.47 M
|
$6.35 M
|
$5.71 M
|
$3.42 M
|
$2.84 M
|
$2.35 M
|
$0.00
|
$0.00
|
| Gross Profit |
-$6.47 M
|
-$6.35 M
|
-$5.71 M
|
-$3.42 M
|
-$2.84 M
|
-$2.35 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$41.11 M
|
$50.48 M
|
$47.25 M
|
$36.46 M
|
$26.51 M
|
$10.09 M
|
$8.49 M
|
$0.00
|
| General & Administrative Expenses |
$25.73 M
|
$31.00 M
|
$28.90 M
|
$0.00
|
$0.00
|
$0.00
|
$1.62 M
|
$111.68 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$25.73 M
|
$31.00 M
|
$28.90 M
|
$23.75 M
|
$21.15 M
|
$3.31 M
|
$1.62 M
|
$111.68 M
|
| Other Expenses |
-$6.47 M
|
-$6.35 M
|
-$5.71 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$60.37 M
|
$75.12 M
|
$70.45 M
|
$60.20 M
|
$47.66 M
|
$13.40 M
|
$10.11 M
|
$111.68 M
|
| Cost And Expenses |
$66.84 M
|
$81.48 M
|
$76.15 M
|
$63.62 M
|
$50.50 M
|
$15.74 M
|
$10.11 M
|
$111.68 M
|
| Interest Income |
$7.87 M
|
$10.78 M
|
$12.55 M
|
$5.82 M
|
$329.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$5.82 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$6.47 M
|
$6.35 M
|
$1.85 M
|
$3.42 M
|
$2.84 M
|
$2.35 M
|
$548.00 K
|
$738.28 M
|
| EBITDA |
-$52.54 M |
-$64.43 M |
-$61.83 M |
-$54.51 M |
-$47.47 M |
-$13.27 M |
-$9.56 M |
$626.60 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$7.84 M
|
$10.70 M
|
$12.48 M
|
$5.69 M
|
$183.00 K
|
$125.00 K
|
$492.00 K
|
$738.28 M
|
| Income Before Tax |
-$59.00 M
|
-$70.78 M
|
-$63.68 M
|
-$57.92 M
|
-$50.32 M
|
-$15.62 M
|
-$9.62 M
|
$626.60 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$59.00 M
|
-$70.78 M
|
-$63.68 M
|
-$57.92 M
|
-$50.32 M
|
-$15.62 M
|
-$9.62 M
|
$626.60 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.47 |
-0.56 |
-0.51 |
-0.46 |
-0.6 |
-0.47 |
-1.59 |
87.18 |
| EPS Diluted |
-0.47 |
-0.56 |
-0.51 |
-0.46 |
-0.6 |
-0.47 |
-1.59 |
87.18 |
| Weighted Average Shares Out |
$126.26 M
|
$125.43 M
|
$124.92 M
|
$124.59 M
|
$84.46 M
|
$33.07 M
|
$6.07 M
|
$7.19 M
|
| Weighted Average Shares Out Diluted |
$126.26 M
|
$125.43 M
|
$124.92 M
|
$124.59 M
|
$84.46 M
|
$33.07 M
|
$6.07 M
|
$7.19 M
|
| Link |
|
|
|
|
|
|
|
|
